Jean-michel M. Molina

Jean-michel M. Molina

Palma, PM, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 341 publications

Comparative characteristics and outcomes of bacterial and fungal skull base osteomyelitis: a retrospective analysis of 127 cases.

Comparative characteristics and outcomes of bacterial and fungal skull base osteomyelitis: a retrospective analysis of 127 cases.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 06, 2026

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial.

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial.

Journal: BMJ open

Published: February 05, 2026

Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.

Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial.

Journal: The lancet. HIV

Published: January 12, 2026

Revisiting gonorrhoea prevention in the era of resistance and biomedical interventions.

Revisiting gonorrhoea prevention in the era of resistance and biomedical interventions.

Journal: Sexually transmitted infections

Published: January 05, 2026

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1.

Analysis of Viral Blips Through Week 192 of the DRIVE-FORWARD and DRIVE-AHEAD Phase 3 Studies of Doravirine-Based Regimens in Adults Living With Previously Untreated HIV-1.

Journal: Open forum infectious diseases

Published: November 13, 2025

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 28, 2025

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 28, 2025

First-generation merozoites of caprine Eimeria christenseni are capable to invade and egress primary host endothelial cells in vitro.

First-generation merozoites of caprine Eimeria christenseni are capable to invade and egress primary host endothelial cells in vitro.

Journal: Frontiers in veterinary science

Published: October 02, 2025

Trajectories of Chemsex Engagement Across Time Among PrEP-Using Men Who Have Sex with Men: Results from the French ANRS-Prévenir Cohort.

Trajectories of Chemsex Engagement Across Time Among PrEP-Using Men Who Have Sex with Men: Results from the French ANRS-Prévenir Cohort.

Journal: International journal of sexual health : official journal of the World Association for Sexual Health

Published: August 22, 2025

Oral and anal shedding of Treponema pallidum in patients with syphilis in the DOXYVAC cohort.

Oral and anal shedding of Treponema pallidum in patients with syphilis in the DOXYVAC cohort.

Journal: Sexually transmitted infections

Published: August 14, 2025

Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study.

Subcutaneous Lenacapavir in People With Multidrug-Resistant HIV-1: 156 Week Results of the CAPELLA Study.

Journal: Open forum infectious diseases

Published: August 05, 2025

Willingness to participate in a long-acting injectable cabotegravir HIV pre-exposure prophylaxis study among men who have sex with men in the French ANRS-PREVENIR cohort.

Willingness to participate in a long-acting injectable cabotegravir HIV pre-exposure prophylaxis study among men who have sex with men in the French ANRS-PREVENIR cohort.

Journal: Sexually transmitted infections

Published: July 02, 2025

Showing 1-12 of 341

Last Updated: 09/26/2026